A Review of the Use of the Dermatology Life Quality Index as a Criterion in Clinical Guidelines and Health Technology Assessments in Psoriasis and Chronic Hand Eczema

被引：19
|
作者：
Basra, Mohammad K. A. [1 ]
Chowdhury, Mahbub M. U. [2 ]
Smith, Emma V. [2 ]
Freemantle, Nick [3 ]
Piguet, Vincent [1 ]
机构：
[1] Cardiff Univ, Sch Med, Dept Dermatol & Wound Healing, Cardiff CF14 4XN, S Glam, Wales
[2] Univ Hosp Wales, Dept Dermatol, Welsh Inst Dermatol, Cardiff CF14 4XW, S Glam, Wales
[3] UCL, Sch Med, Dept Primary Care & Populat Hlth, London NW3 2PF, England
来源：
DERMATOLOGIC CLINICS | 2012年 / 30卷 / 02期
关键词：
Chronic hand eczema; Psoriasis; Quality of life; Dermatology Life Quality Index (DLQI); OF-LIFE; COST-EFFECTIVENESS; ORAL ALITRETINOIN; DOUBLE-BLIND; SEVERITY; ETANERCEPT; PREVALENCE; THERAPY; QUESTIONNAIRE; PRODUCTIVITY;
D O I：
10.1016/j.det.2011.11.002
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
The Dermatology Life Quality Index (DLQI) is an easy and practical way of quantifying the impact of skin disease. The role of DLQI in treatment guidelines and its emergence as an eligibility and response criterion in health technology appraisal are discussed. This review analyzes the current available literature on the clinical use of the DLQI, with particular reference to its relationship with disease severity and as a criterion in the assessment of health technology. The need for future studies of chronic hand eczema to incorporate DLQI to document quality-of-life outcomes with new treatments is also discussed.
引用
收藏
页码：237 / +
页数：9
相关论文
共 50 条
  • [31] Health-Related Quality of Life in Chronic Hand Eczema in a Phase 2b Trial of Delgocitinib Cream
    Buhl, Timo
    Bauer, Andrea
    Ehst, Benjamin D.
    Thyssen, Jacob P.
    Hahn-Pedersen, Julie
    Hagen, Berith Fredsted
    Apol, Eydna D.
    Agner, Tove
    DERMATOLOGY AND THERAPY, 2025, : 1181 - 1193
  • [32] Patient-assessed disease severity is a strong determinant of health-related quality of life in chronic hand eczema
    Apfelbacher, C.
    Weisshaar, E.
    Molin, S.
    Bauer, A.
    Mahler, V.
    Matterne, U.
    Weiss, N.
    Schmitt, J.
    Ruzicka, T.
    Elsner, P.
    Diepgen, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S101 - S101
  • [33] Chronic hand eczema: A prevalent disease in the general population associated with reduced quality of life and poor overall health measures
    Quaade, Anna Sophie
    Alinaghi, Farzad
    Dietz, Jojo Biel-Nielsen
    Erichsen, Christina Yndal
    Johansen, Jeanne Duus
    CONTACT DERMATITIS, 2023, 89 (06) : 453 - 463
  • [34] Self-assessed disease severity is a powerful predictor of health-related quality of life in chronic hand eczema
    Apfelbacher, C.
    Matterne, U.
    Weiss, M.
    Molin, S.
    Weisshaar, E.
    Bauer, A.
    Mahler, V.
    Schmitt, J.
    Ruzicka, T.
    Elsner, P.
    Diepgen, T. L.
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (03) : E23 - E23
  • [35] Chronic hand eczema: A prospective analysis of the Swiss CARPE registry focusing on factors associated with clinical and quality of life improvement
    Cazzaniga, Simone
    Ballmer-Weber, Barbara K.
    Grani, Nora
    Spring, Philippe
    Bircher, Andreas
    Anliker, Mark
    Sonntag, Anne-Katharina
    Piletta, Pierre
    Huber, Caroline
    Diepgen, Thomas L.
    Apfelbacher, Christian
    Naldi, Luigi
    Borradori, Luca
    Simon, Dagmar
    CONTACT DERMATITIS, 2018, 79 (03) : 136 - 148
  • [36] Correlation Between Change in Psoriasis Area and Severity Index and Dermatology Life Quality Index in Patients with Psoriasis: Pooled Analysis from Four Phase 3 Clinical Trials of Secukinumab
    Katherine Houghton
    Dhaval Patil
    Braulio Gomez
    Steven R. Feldman
    Dermatology and Therapy, 2021, 11 : 1373 - 1384
  • [37] Clinical responses to treatment and changes in the Dermatology Life Quality Index (DLQI) in moderate to severe plaque psoriasis patients treated with adalimumab
    Shikiar, R
    Thompson, C
    Melilli, LE
    VALUE IN HEALTH, 2005, 8 (06) : A13 - A13
  • [38] Correlation Between Change in Psoriasis Area and Severity Index and Dermatology Life Quality Index in Patients with Psoriasis: Pooled Analysis from Four Phase 3 Clinical Trials of Secukinumab
    Houghton, Katherine
    Patil, Dhaval
    Gomez, Braulio
    Feldman, Steven R.
    DERMATOLOGY AND THERAPY, 2021, 11 (04) : 1373 - 1384
  • [39] Time, Psoriasis Area and Severity Index and Dermatology Life Quality Index of patients with psoriasis who drop out of clinical trials on etanercept because of lack of efficacy: a pooled analysis from 10 clinical trials
    Nast, A.
    Dilleen, M.
    Liyanage, W.
    Aikman, L.
    Szczypa, P.
    Dressler, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 400 - 405
  • [40] Correlation of Venous Clinical Severity Score and Venous Disability Score with Dermatology Life Quality Index in Chronic Venous Insufficiency
    Mallick, Subhadeep
    Sarkar, Tanusree
    Gayen, Tirthankar
    Naskar, Biswanath
    Datta, Adrija
    Sarkar, Somenath
    INDIAN JOURNAL OF DERMATOLOGY, 2020, 65 (06) : 489 - 494
12345